Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Javelin Pharmaceuticals, Inc. (NYSE - Amex: JAV), today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned subsidiary of...
DALLAS, June 30, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Javelin Pharmaceuticals Inc. (AMEX:JAV). The report includes financial, comparative and...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") announces that on June 18, 2010, Business Wire, a news release service, inadvertently issued a hoax press release...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") today announced that Hospira, Inc. ("Hospira") funded a $2 million loan to Javelin on June 10, 2010 under the...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") today announced that on June 4, 2010, Javelin received notice from Hospira, Inc. ("Hospira") that Hospira will fund...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") announces that on May 28, 2010, Javelin received notice from the staff of the NYSE Amex LLC (the “Exchange”) that...
Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") today announced that it has filed a lawsuit against Hospira, Inc. ("Hospira") and Discus Acquisition Corporation, a...
Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV), a leading developer of novel acute care pain products, today announced that Therabel Pharma UK Limited ("Therabel"), a subsidiary...
Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV), a leading developer of novel acute care pain products, commented on the tender offer extension by Hospira, Inc. Hospira...
Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV - News), a leading developer of novel acute care pain products, today reported its unaudited financial results for the first...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Symbol | Preis | Vol. |
|---|---|---|
| MSTZT Rex 2X Inverse MSTR Daily Target ETF | US$ 0,9467 (-11,52%) | 795,18M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,22 (6,62%) | 56,33M |
| FXIiShares China Large Cap | US$ 29,69 (-2,17%) | 53,99M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 28,49 (0,00%) | 50,44M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,035 (-0,74%) | 49,69M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
